Morgan Stanleyの空売り状況は、投資家がMorgan Stanleyの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Morgan Stanley (NYSE:MS) 株価情報, 空売り情報

Morgan Stanley

Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 30% of its total revenue is from outside the Americas. The company had over $5 trillion of client assets as well as around 80,000 employees at the end of 2023.

MSA Safety Inc

MS&AD INS GRP HLDGS ORD by MS&AD Insurance Group Holdings, Inc.

MS&AD Insurance Group Holdings Inc

MS&AD INS GRP HL UNSP/ADR by MS&AD Insurance Group Holdings, Inc.

MAN SHING AGRICULTRL HLDG by Man Shing Agricultural Holdings, Inc.

Man Shing Agricultural Holdings Inc

MultiSensor AI Holdings, Inc. - Common Stock

MultiSensor AI Holdings Inc

INVESCO MSCI SAUDI ARABIA UCITS ETF

INVESCO MARKETS PLC - INVESCO MSCI SAUDI ARABIA UCITS ETF ETF ON MSCI SAUDI ARABIA ETF

Mesabi Trust

Misbloc

MERCER BANCORP INC by Mercer Bancorp, Inc.

Mercer Bancorp Inc

Mission Bancorp

Mitsubishi Corp

Midland States Bancorp, Inc. - Common Stock

Midland States Bancorp Inc

Midland States Bancorp, Inc. - Depositary Shares Each Representing a 1/40th Interest in a Share of 7.750% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series A

MSB GLOBAL CAPITAL CORP by MSB Global Capital Corp.

MSB Global Capital Corp

Messaben Corp

MITSUBISHI PENCIL CO LTD by Mitsubishi Pencil Co Ltd

Mitsubishi Pencil Co Ltd

Studio City International Holdings Limited American depositary shares, each representing four Class A ordinary shares

Studio City International Holdings Ltd

MICROSEMI ORD

MSC Income Fund Inc

MAKING SCIENCE GROUP S A by MAKING SCIENCE GROUP S A

Making Science Group SA

MAINSTREETCHAMBER HOLDING by MainStreetChamber Holdings Inc.

MainStreetChamber Holdings Inc

MSCI Inc

SATELLOS BIOSCIENCE INC by SATELLOS BIOSCIENCE INC.

Satellos Bioscience Inc

MALAYSIA SMELTING CP BHD by Malaysia Smelting Corp Bhd

Morgan Stanley Emerging Markets Debt Fund, Inc. Common Stock

Morgan Stanley Emerg Mkts Debt Fd Inc

Morgan Stanley Direct Lending Fund Common Stock

Morgan Stanley Direct Lending Fund

AIS MSCI Em Mkts SRIUCTSETFDRD

MAGSEIS FAIRFIELD ASA by MAGSEIS FAIRFIELD ASA

Mustek Ltd

MADISON SPORTS & ENTMT GP by Madison Sports & Entertainment Group, Inc.

Madison Sports & Entertainment Group

AMUNDI EURO STOXX 50 II UCITS ETF

Middlesex Water Co

MIDDLESEX WATER 7 PR by Middlesex Water Co.

MEDIA SENTIMENT INC by Media Sentiment, Inc.

Media Sentiment Inc

Mao Shi Jade Jewelry International Investment Ltd

Direxion Daily MSFT Bear 1X Shares

HARVEST MICROSOFT HG CL U UNT ETF

GraniteShares 2x Long MSFT Daily ETF

MAINSTREET FINL CORP MICH by Mainstreet Financial Corp.

MainStreet Financial Corp

Tidal ETF Trust II YieldMax MSFT Option Income Strategy ETF

Microsoft Corp

MICROSOFT ORD

Direxion Daily MSFT Bull 2X Shares

ETF Opportunities Trust T-Rex 2X Long Microsoft Daily Target ETF

NEOS ETF Trust Kurv Yield Premium Strategy Microsoft (MSFT) ETF

Mas Gold Corp

Madison Square Garden Entertainment Corp. Class A Common Stock

Madison Square Garden Entertainment Corp

Motorsport Games Inc. - Class A Common Stock

Motorsport Games Inc

MAN SANG INTL LTD NEW by Man Sang International Ltd.

Man Sang International Ltd

MEDSMART GROUP INC by MedSmart Group Inc.

MedSmart Group Inc

Madison Square Garden Sports Corp. Class A Common Stock (New)

Madison Square Garden Sports Corp

MSH ENTERTAINMENT CORP by MSH Entertainment Corp.

HARVEST MICROSOFT END CL U UNT ETF

MENSCH UND MSCHINE SOFTWR by MENSCH UND MASCHINE SOFTWARE SE

Mensch und Maschine Software SE

MITSUBISHI SHOKUHIN CO by Mitsubishi Shokuhin Co Ltd.

Mitsubishi Shokuhin Co Ltd

Motorola Solutions Inc

MEDICAL SVCS INTL INC by Medical Services International Inc.

Medical Services International Inc

MEDICAL SUPPLY INTL USA by Medical Supply International USA, Inc.

Medical Supply International USA Inc

MASCOT SILVER LEAD MINES by Mascot Silver-Lead Mines, Inc.

MITSUI O.S.K. LINES NEW by Mitsui O.S.K. Lines Ltd.

Mitsui O.S.K. Lines Ltd

MITSUI O.S.K. LINES U/ADR by Mitsui O.S.K. Lines Ltd.

MusclePharm Corp

Mantaro Precious Metals Corp Ordinary Shares

FIRST ANDES SILVER LTD by FIRST ANDES SILVER LTD.

First Andes Silver Ltd

MSC Industrial Direct Company, Inc. Common Stock

MSC Industrial Direct Co Inc

MIMASU SEMICNDCTR IND ORD by Mimasu Semiconductor Industry Co., Ltd.

Mimasu Semiconductor Industry Co Ltd

Grid Metals Corp

MATSUMOTOKIYOSHI HLDG ORD by Matsumotokiyoshi Holdings Co., Ltd.

MatsukiyoCocokara & Co

Whales with a lot of money to spend have taken a noticeably bearish stance on Morgan Stanley.
Looking at options history for Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) we detected 20 trades.
If we consider the specifics of each trade, it is accurate to state that 25% of the investors opened trades with bullish expectations and 65% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $272,134 and 16, calls, for a total amount of $1,768,416.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $95.0 to $115.0 for Morgan Stanley over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Morgan Stanley options trades today is 1971.21 with a total volume of 3,792.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Morgan Stanley's big money trades within a strike price range of $95.0 to $115.0 over the last 30 days.
<h3>Morgan Stanley Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728062180_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$9.05</td>
<td>$8.9</td>
<td>$9.0</td>
<td>$100.00</td>
<td>$630.0K</td>
<td>1.7K</td>
<td style="text-align: right;">739</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/04/24</td>
<td>$6.0</td>
<td>$5.75</td>
<td>$5.7</td>
<td>$102.00</td>
<td>$199.5K</td>
<td>1.0K</td>
<td style="text-align: right;">358</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>11/15/24</td>
<td>$5.25</td>
<td>$5.15</td>
<td>$5.2</td>
<td>$105.00</td>
<td>$140.9K</td>
<td>7.1K</td>
<td style="text-align: right;">367</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/04/24</td>
<td>$13.3</td>
<td>$12.45</td>
<td>$12.59</td>
<td>$95.00</td>
<td>$126.1K</td>
<td>306</td>
<td style="text-align: right;">61</td>
</tr>
<tr>
<td>MS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$5.45</td>
<td>$5.4</td>
<td>$5.4</td>
<td>$105.00</td>
<td>$104.2K</td>
<td>102</td>
<td style="text-align: right;">45</td>
</tr>
</tbody>
</table>

<h3>About Morgan Stanley</h3>
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 30% of its total revenue is from outside the Americas. The company had over $5 trillion of client assets as well as around 80,000 employees at the end of 2023.
Following our analysis of the options activities associated with Morgan Stanley, we pivot to a closer look at the company's own performance.
<h3>Morgan Stanley's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 2,391,337, the MS's price is up by 2.55%, now at $107.24. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 12 days.</li>
</ul>
<h3>Professional Analyst Ratings for Morgan Stanley</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $109.66666666666667.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from HSBC has elevated its stance to Buy, setting a new price target at $118. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Neutral rating on Morgan Stanley, which currently sits at a price target of $106. 
&#x2A; In a cautious move, an analyst from Goldman Sachs downgraded its rating to Neutral, setting a price target of $105. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Morgan Stanley options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

Morgan Stanley's Options: A Look at What the Big Money is Thinking

WIIM

Morgan Stanley shares are trading higher after HSBC upgraded the stock from Hold to Buy and announced a $118 price target.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>HSBC analyst Saul Martinez upgraded Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) from Hold to Buy and announced a price target of $118. Morgan Stanley shares gained 0.1% to close at $104.57 on Thursday. <a href="https://www.benzinga.com/quote/MS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wolfe Research analyst Bill Carcache upgraded the rating for M&amp;T Bank Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>) from Peer Perform to Outperform and announced a $210 price target. M&amp;T Bank shares fell 0.5% to close at $172.34 on Thursday. <a href="https://www.benzinga.com/quote/MTB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>TD Cowen analyst Charles Ryhee upgraded CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) from Hold to Buy and boosted the price target from $59 to $85. CVS Health shares rose 1.1% to close at $62.92 on Thursday. <a href="https://www.benzinga.com/quote/CVS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst Robert Kad upgraded The Williams Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMB#NYSE">WMB</a>) from Equal-Weight to Overweight and raised the price target from $52 to $58. Williams shares gained 1.2% to close at $48.21 on Thursday. <a href="https://www.benzinga.com/quote/WMB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BMO Capital analyst Phillip Jungwirth upgraded the rating for Diamondback Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) from Market Perform to Outperform and raised the price target from $205 to $215. Diamondback Energy shares gained 3.9% to close at $188.30 on Thursday. <a href="https://www.benzinga.com/quote/FANG/analyst-ratings">See how other analysts view this stock</a>. </li>
</ul>
Considering buying MS stock? Here&#8217;s what analysts think.
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="517" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04085737/image-2-10-1024x517.png" alt="" class="wp-image-580686" style="width:572px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04085737/image-2-10-1024x517.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04085737/image-2-10-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04085737/image-2-10-768x388.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04085737/image-2-10.png 1337w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41180069/dow-tumbles-nearly-200-points-amid-growing-middle-east-concerns-investor-optimism-declines-fear-ind">Dow Tumbles Nearly 200 Points Amid Growing Middle East Concerns: Investor Optimism Declines, Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

News

Upgrades

Pre-Market Outlook

Analyst Ratings

Trading Ideas

FANG

This Morgan Stanley Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

HSBC analyst Saul Martinez upgrades Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) from Hold to Buy and announces $118 price target.

Price Target

HSBC Upgrades Morgan Stanley to Buy, Announces $118 Price Target

After securing a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41175197/openais-latest-eye-popping-valuation-ignites-analyst-expectations-for-tidal-wave-of">whopping $6.6 billion funding</a> round, ChatGPT-parent&nbsp;OpenAI has bagged a&nbsp;$4 billion revolving credit line.
What Happened: The new credit facility will bolster its liquidity to $10 billion, allowing the AI startup to invest in high-cost <a href="https://www.benzinga.com/markets/equities/24/07/39856365/openai-in-talks-with-broadcom-to-develop-new-ai-chip-aims-to-reduce-reliance-on-nvidia-report">computing capacity</a> including Nvidia Corporation&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) chips.
&#8220;This credit facility further strengthens&nbsp;our balance sheet and provides&nbsp;flexibility to seize future growth&nbsp;opportunities,&#8221; said OpenAI CFO&nbsp;Sarah Friar, in a blog on Thursday.
The credit line is facilitated by a consortium of banks: JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), Citigroup, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), Goldman Sachs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), Banco Santander S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAN#NYSE">SAN</a>), Wells Fargo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>), Sumitomo Mitsui Banking&nbsp;Corporation, UBS Group AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBS#NYSE">UBS</a>), and HSBC Holdings plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSBC#NYSE">HSBC</a>).
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: Earlier this week, OpenAI, <a href="https://www.benzinga.com/news/24/10/41149788/openai-valuation-soars-to-157b-in-latest-funding-round">valued at nearly $157 billion</a>, raised funds&nbsp;from returning venture capital investors&nbsp;such as&nbsp;Thrive Capital and Khosla Ventures.
Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), which has already invested approximately $13 billion into the AI firm over the last five years,&nbsp;and new investor Nvidia, also&nbsp;participated in the funding round.
Despite <a href="https://www.benzinga.com/news/24/09/41059344/sam-altman-hits-back-at-trolls-after-mira-muratis-openai-exit-explains-executive-drain-as-natural-we">major executive changes</a>, including the sudden exit of CTO Mira Murati, investors remain optimistic about OpenAI&#8217;s growth prospects.
However, OpenAI has also faced criticism from Elon Musk, who accused the company of&nbsp;<a href="https://www.benzinga.com/news/24/10/41156902/elon-musk-says-openai-is-evil-after-chatgpt-parent-reportedly-asked-investors-not-to-invest-in-rival">unfair funding practices</a>.
On the other hand, analysts expect a &#8220;tidal wave&#8221; of AI spending, with OpenAI&#8217;s latest valuation seen as a trigger for this growth stage.
Photo Courtesy: Shutterstock
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41111038/elon-musk-gets-bold-font-removed-from-xs-main-timeline-because-of-excessive-use-my-eyes-are-bleeding?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Gets Bold Font Removed From X&#8217;s Main Timeline Because Of &#8216;Excessive&#8217; Use: &#8216;My Eyes Are Bleeding&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Tech

HSBC

MSFT

NVDA

OpenAI Secures $4B Credit Line To Supercharge AI Ambitions And Expand Nvidia-Powered Infrastructure: 'Provides Flexibility To Seize Future Growth Opportunities'

Across the recent three months, 9 analysts have shared their insights on Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Morgan Stanley, presenting an average target of $108.67, a high estimate of $121.00, and a low estimate of $95.00. This upward trend is evident, with the current average reflecting a 4.74% increase from the previous average price target of $103.75.
<img src="https://www.benzinga.com/files/images/story/2024/1727899351_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The perception of Morgan Stanley by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Richard Ramsden</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$106.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Richard Ramsden</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Neutral</td>
<td>$105.00</td>
<td>-</td>
</tr>
<tr>
<td>Whit Mayo</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$95.00</td>
<td>$99.00</td>
</tr>
<tr>
<td>James Fotheringham</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$118.00</td>
<td>$116.00</td>
</tr>
<tr>
<td>Keith Horowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$105.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Jason Goldberg</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$121.00</td>
<td>$116.00</td>
</tr>
<tr>
<td>Glenn Schorr</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$115.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Gerard Cassidy</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$108.00</td>
<td>$91.00</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$105.00</td>
<td>$100.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Morgan Stanley. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Morgan Stanley compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Morgan Stanley's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Morgan Stanley's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/MS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Morgan Stanley analyst ratings.</a>
<h2>Delving into Morgan Stanley's Background</h2>
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 30% of its total revenue is from outside the Americas. The company had over $5 trillion of client assets as well as around 80,000 employees at the end of 2023.
<h3>Morgan Stanley: Financial Performance Dissected</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Positive Revenue Trend: Examining Morgan Stanley's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 11.46% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Morgan Stanley's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 20.98%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Morgan Stanley's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 3.23%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.24%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 3.18, caution is advised due to increased financial risk.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Morgan Stanley's Future

Goldman Sachs analyst Richard Ramsden maintains Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) with a Neutral and raises the price target from $105 to $106.

Goldman Sachs Maintains Neutral on Morgan Stanley, Raises Price Target to $106

Financial giants have made a conspicuous bullish move on Morgan Stanley. Our analysis of options history for Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) revealed 8 unusual trades.
Delving into the details, we found 62% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $126,600, and 5 were calls, valued at $335,399.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $100.0 to $105.0 for Morgan Stanley during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Morgan Stanley's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Morgan Stanley's significant trades, within a strike price range of $100.0 to $105.0, over the past month.
<h3>Morgan Stanley 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727365628_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$6.75</td>
<td>$6.65</td>
<td>$6.75</td>
<td>$105.00</td>
<td>$132.3K</td>
<td>1.0K</td>
<td style="text-align: right;">237</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$3.15</td>
<td>$3.1</td>
<td>$3.1</td>
<td>$104.00</td>
<td>$91.4K</td>
<td>163</td>
<td style="text-align: right;">435</td>
</tr>
<tr>
<td>MS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$3.3</td>
<td>$3.25</td>
<td>$3.3</td>
<td>$105.00</td>
<td>$66.0K</td>
<td>3.2K</td>
<td style="text-align: right;">249</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$8.4</td>
<td>$8.3</td>
<td>$8.4</td>
<td>$100.00</td>
<td>$47.8K</td>
<td>14.7K</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$3.05</td>
<td>$2.98</td>
<td>$3.05</td>
<td>$104.00</td>
<td>$36.2K</td>
<td>163</td>
<td style="text-align: right;">1</td>
</tr>
</tbody>
</table>

<h3>About Morgan Stanley</h3>
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 30% of its total revenue is from outside the Americas. The company had over $5 trillion of client assets as well as around 80,000 employees at the end of 2023.
Following our analysis of the options activities associated with Morgan Stanley, we pivot to a closer look at the company's own performance.
<h3>Current Position of Morgan Stanley</h3>
<ul>
<li>With a volume of 1,349,756, the price of MS is up 1.56% at $103.94. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 20 days.</li>
</ul>
<h3>Expert Opinions on Morgan Stanley</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $105.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Goldman Sachs has revised its rating downward to Neutral, adjusting the price target to $105. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Morgan Stanley options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Market Whales and Their Recent Bets on Morgan Stanley Options

Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) has outperformed the market over the past 5 years by 5.55% on an annualized basis producing an average annual return of 19.74%. Currently, Morgan Stanley has a market capitalization of $164.78 billion. 
Buying $1000 In MS: If an investor had bought $1000 of MS stock 5 years ago, it would be worth $2,386.92 today based on a price of $101.85 for MS at the time of writing.
<h3>Morgan Stanley's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727287230_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,400 Today

In October 2023, Sanofi SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) announced its plans to spin off its consumer healthcare business as the French pharmaceutical company outlined its strategic update to increase investment in its drug-development <a target="_blank" href="https://www.benzinga.com/general/biotech/23/10/35458838/sanofi-goes-the-rival-way-plans-separation-of-consumer-healthcare-unit" rel="noreferrer noopener">pipeline and cut costs</a>.
Sanofi said the spinoff would allow it to increase its focus on innovative medicines and vaccines.
Sanofi&#8217;s consumer health unit boasts a portfolio that includes popular over-the-counter products like Phytoxil cough syrups, Icy Hot pain relief gels, and Dulcolax laxative tablets.&nbsp;
According to a Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-09-24/sanofi-said-to-get-binding-bids-from-cd-r-pai-for-consumer-arm?srnd=prognosis&amp;embedded-checkout=true" rel="noreferrer noopener">report</a>, two private equity firms, Clayton Dubilier &amp; Rice and PAI Partners, made separate bids for Sanofi&#8217;s consumer health division.
The update pushes the European pharma giant closer to one of the largest European deals this year, which could value the unit at 15 billion euros ($16.8 billion) or more, the Bloomberg report added.
The separation is expected to occur by Q4 2024 by creating a publicly listed entity headquartered in France.
In July, Goldman Sachs Group Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) and&nbsp;Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) said they were preparing to arrange more than $6.5 billion (6 billion euros) in debt financing for potential buyers interested in acquiring&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/07/39755459/sanofis-20b-consumer-health-unit-sale-goldman-sachs-morgan-stanley-line-up-6-5b-financing" rel="noreferrer noopener">Sanofi&#8217;s&nbsp;consumer health division</a>.
The move highlighted banks&#8217; interest in supporting leveraged buyouts through pre-arranged financing.
Sanofi may opt for a spinoff of its consumer health business if the offers aren&#8217;t appealing, Bloomberg noted, citing sources. A company spokesperson told Bloomberg that Sanofi is evaluating potential separation options, with the earliest possible transaction happening in the fourth quarter of this year, and noted that preparations are progressing as planned.
In November 2023, Sanofi reportedly initiated talks with Rothschild &amp; Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business <a target="_blank" href="https://www.benzinga.com/markets/equities/23/11/35823034/major-buyout-firms-eye-sanofis-consumer-health-division-spinoff-valued-over-20b" rel="noreferrer noopener">at over $20 billion</a>.&nbsp;
Rival pharma giants&nbsp;GSK Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>)&nbsp;and&nbsp;Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) split their consumer healthcare units&nbsp;Haleon Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLN#NYSE">HLN</a>) and Kenvue Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>), respectively.
Price Action: SNY stock closed at $57.62&nbsp;on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/24/09/41012667/healthcare-software-giant-epic-systems-hit-with-lawsuit-over-alleged-monopolistic-practices" target="_blank" rel="noreferrer noopener">Healthcare Software Giant Epic Systems Hit With Lawsuit Over Alleged Monopolistic Practices</a>.</li>
</ul>
Photo via Company

Biotech

Large Cap

Health Care

Rumors

Media

General

KVUE

Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff

Investors with a lot of money to spend have taken a bearish stance on Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MS, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for Morgan Stanley.
This isn't normal.
The overall sentiment of these big-money traders is split between 12% bullish and 87%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $115,490, and 6 are calls, for a total amount of $341,396.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $85.0 to $109.0 for Morgan Stanley over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Morgan Stanley's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Morgan Stanley's whale trades within a strike price range from $85.0 to $109.0 in the last 30 days. 
<h3>Morgan Stanley 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727115343_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$1.19</td>
<td>$1.06</td>
<td>$1.16</td>
<td>$107.00</td>
<td>$105.3K</td>
<td>0</td>
<td>1.0K</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$1.2</td>
<td>$1.17</td>
<td>$1.17</td>
<td>$107.00</td>
<td>$81.9K</td>
<td>0</td>
<td>2.5K</td>
</tr>
<tr>
<td>MS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$3.35</td>
<td>$3.15</td>
<td>$3.35</td>
<td>$85.00</td>
<td>$81.7K</td>
<td>235</td>
<td>264</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$1.2</td>
<td>$1.18</td>
<td>$1.18</td>
<td>$107.00</td>
<td>$52.6K</td>
<td>0</td>
<td>3.0K</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/27/24</td>
<td>$1.1</td>
<td>$1.08</td>
<td>$1.08</td>
<td>$102.00</td>
<td>$41.9K</td>
<td>1.9K</td>
<td>1.0K</td>
</tr>
</tbody>
</table>

<h3>About Morgan Stanley</h3>
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 30% of its total revenue is from outside the Americas. The company had over $5 trillion of client assets as well as around 80,000 employees at the end of 2023.
Following our analysis of the options activities associated with Morgan Stanley, we pivot to a closer look at the company's own performance.
<h3>Current Position of Morgan Stanley</h3>
<ul>
<li>Currently trading with a volume of 1,573,290, the MS's price is down by -0.42%, now at $102.04. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 23 days.</li>
</ul>
<h3>What Analysts Are Saying About Morgan Stanley</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $105.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Goldman Sachs downgraded its rating to Neutral, setting a price target of $105. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Morgan Stanley with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

A Closer Look at Morgan Stanley's Options Market Dynamics

Investors with a lot of money to spend have taken a bearish stance on Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MS, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 8 options trades for Morgan Stanley.
This isn't normal.
The overall sentiment of these big-money traders is split between 25% bullish and 50%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $48,850, and 7, calls, for a total amount of $497,736.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $80.0 to $105.0 for Morgan Stanley during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Morgan Stanley stands at 5764.14, with a total volume reaching 1,318.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Morgan Stanley, situated within the strike price corridor from $80.0 to $105.0, throughout the last 30 days.
<h3>Morgan Stanley Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726777913_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$6.85</td>
<td>$6.75</td>
<td>$6.8</td>
<td>$100.00</td>
<td>$125.8K</td>
<td>14.8K</td>
<td style="text-align: right;">206</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$23.0</td>
<td>$22.9</td>
<td>$22.9</td>
<td>$80.00</td>
<td>$103.0K</td>
<td>56</td>
<td style="text-align: right;">50</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$4.3</td>
<td>$4.2</td>
<td>$4.2</td>
<td>$105.00</td>
<td>$84.0K</td>
<td>7.8K</td>
<td style="text-align: right;">211</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/18/24</td>
<td>$3.9</td>
<td>$3.8</td>
<td>$3.85</td>
<td>$100.00</td>
<td>$57.3K</td>
<td>3.5K</td>
<td style="text-align: right;">379</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$8.45</td>
<td>$8.35</td>
<td>$8.45</td>
<td>$97.50</td>
<td>$50.7K</td>
<td>220</td>
<td style="text-align: right;">63</td>
</tr>
</tbody>
</table>

<h3>About Morgan Stanley</h3>
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 30% of its total revenue is from outside the Americas. The company had over $5 trillion of client assets as well as around 80,000 employees at the end of 2023.
Having examined the options trading patterns of Morgan Stanley, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Morgan Stanley's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 9,054,366, the MS's price is up by 1.44%, now at $100.73. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 27 days.</li>
</ul>
<h3>Expert Opinions on Morgan Stanley</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $105.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Goldman Sachs lowers its rating to Neutral with a new price target of $105.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Morgan Stanley, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Looking At Morgan Stanley's Recent Unusual Options Activity

BGC Group Inc., (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGC#NASDAQ">BGC</a>) a financial services firm led by Cantor Fitzgerald CEO Howard Lutnick, plans to launch an exchange that will start trading <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40423424/donald-trump-names-howard-lutnick-to-lead-transition-team-heres-what-it-means-for-crypto">secured overnight financing rate</a> (SOFR) futures on Sept. 23 on its new FMX Futures Exchange.
The SOFR is a benchmark interest rate for dollar-denominated derivatives and loans that replaced the London Interbank Offered Rate (LIBOR) in June 2023.
&#8220;I think we&#8217;re going to bring competition into the market and I&#8217;m jazzed, jazzed, jazzed,&#8221; Lutnick said in announcing the new exchange on Bloomberg Television on Wednesday.
 FMX Futures Exchange is a consortium backed by Bank of America Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), Barclays (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCS#NYSE">BCS</a>), Citadel Securities, Citigroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), The Goldman Sachs Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), J.P.Morgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), Jump Trading Group and Tower Research.
On April 25, these financial services companies together bought a 26% stake in FMX for $172 million, which valued the exchange at $667 million. BGC gave the partners an additional 10% stake contingent upon them hitting certain volume targets, Piper Sandler analyst Patrick Moley wrote in a note on Thursday.
Moley noted that FMX&#8217;s intent is to take some of the Chicago Mercantile Exchange&#8217;s (CME) total monopoly SOFR futures, which make up 30% to 40% of CME&#8217;s interest rate derivative volumes.
Read Also: <a href="https://editorial.benzinga.com/wp-admin/post.php?post=545008&amp;action=edit">Will Trump Body-Slam 2024 Election? New Transition Team Co-Chair Led WWE For Decades</a>
&#8220;We&#8217;re going to create a break in the monopoly built by the Chicago Mercantile Exchange,&#8221; Lutnick said Wednesday. &#8220;It&#8217;s so fun and it&#8217;s so exciting.&#8221;
FMX plans to start trading U.S. Treasury futures in next year&#8217;s first quarter.
FMX is not expected to take "meaningful" market share from CME in interest rate futures until the third year after its launch, Moley said.
&#8220;However, CEO Lutnick believes FMX will have record open interest for a new exchange at the end of year 1,&#8221; he wrote.
Moley said that CME CEO Terry Duffy believes that U.S. regulations will not allow FMX to succeed, given that trades will be cleared by LCH Group, a London-based clearing house.
But Lutnick disagrees with Duffy, Moley said. As a Commodity Futures Trading Commission-recognized organization, it will be clearing trades through a U.S. subsidiary on U.S. soil.
&#8220;Bottom line, FMX has all the regulatory approvals / registrations needed to launch on September 23rd,&#8221; Moley wrote.
&#8220;And while CEO Duffy believes the U.S. government / regulators will eventually intervene and possibly block FMX's use of clearing partner LCH (which we believe would ultimately lead to FMX failing to succeed in IR futures), there is no evidence to suggest this will occur at this point in time.&#8221;
BCG Price Action: BCG Group ticked up 0.11% to $9.26 into Thursday&#8217;s early afternoon trading.
Read Now:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/23/05/32120885/cantor-fitzgerald-discontinues-research-coverage-of-the-cannabis-sector">Cantor Fitzgerald Discontinues Research Coverage Of The Cannabis Sector</a></li>
</ul>

Analyst Color

Equities

Government

Futures

Treasuries

BGC Group To Trade Futures On New Exchange: CEO Lutnick Is 'Jazzed, Jazzed, Jazzed'

Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) has outperformed the market over the past 5 years by 4.04% on an annualized basis producing an average annual return of 16.8%. Currently, Morgan Stanley has a market capitalization of $155.49 billion. 
Buying $100 In MS: If an investor had bought $100 of MS stock 5 years ago, it would be worth $214.77 today based on a price of $96.11 for MS at the time of writing.
<h3>Morgan Stanley's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726075842_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today

Morgan Stanley shares are trading lower after Goldman Sachs downgraded the stock from Buy to Neutral.

Goldman Sachs analyst Richard Ramsden downgrades Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) from Buy to Neutral and announces $105 price target.

Downgrades

Goldman Sachs Downgrades Morgan Stanley to Neutral, Announces $105 Price Target

Investors with a lot of money to spend have taken a bullish stance on Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MS, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 12 uncommon options trades for Morgan Stanley.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 50%, bearish.
Out of all of the special options we uncovered, 9 are puts, for a total amount of $550,052, and 3 are calls, for a total amount of $173,860.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $90.0 to $105.0 for Morgan Stanley over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Morgan Stanley's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Morgan Stanley's substantial trades, within a strike price spectrum from $90.0 to $105.0 over the preceding 30 days.
<h3>Morgan Stanley Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725993943_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$3.75</td>
<td>$3.65</td>
<td>$3.65</td>
<td>$92.50</td>
<td>$178.8K</td>
<td>1.5K</td>
<td style="text-align: right;">491</td>
</tr>
<tr>
<td>MS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$4.6</td>
<td>$4.5</td>
<td>$4.5</td>
<td>$90.00</td>
<td>$117.6K</td>
<td>715</td>
<td style="text-align: right;">224</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$6.05</td>
<td>$5.95</td>
<td>$5.95</td>
<td>$100.00</td>
<td>$98.2K</td>
<td>423</td>
<td style="text-align: right;">115</td>
</tr>
<tr>
<td>MS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$3.1</td>
<td>$3.0</td>
<td>$3.1</td>
<td>$95.00</td>
<td>$77.5K</td>
<td>5.9K</td>
<td style="text-align: right;">189</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/11/24</td>
<td>$0.56</td>
<td>$0.38</td>
<td>$0.38</td>
<td>$105.00</td>
<td>$48.7K</td>
<td>45</td>
<td style="text-align: right;">41</td>
</tr>
</tbody>
</table>

<h3>About Morgan Stanley</h3>
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 30% of its total revenue is from outside the Americas. The company had over $5 trillion of client assets as well as around 80,000 employees at the end of 2023.
Following our analysis of the options activities associated with Morgan Stanley, we pivot to a closer look at the company's own performance.
<h3>Morgan Stanley's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 5,048,416, the MS's price is down by -1.93%, now at $96.29. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 36 days.</li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Morgan Stanley with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Smart Money Is Betting Big In Morgan Stanley Options

CACC

CFBK

CRBG

FSFG

HBAN

NYCB

VBFC

Shares of bank stocks are trading lower in possible sympathy with Ally, which fell after the company's CFO noted credit challenges among borrowers. The sector earlier reacted to Fed Vice Chair for Supervision Barr previewing Basel and GSIB surcharge re-proposals.

Morgan Stanley's Simkowitz Says Bank Has $500B In Private Markets

Morgan Stanley Co-President Dan Simkowitz Says Clients Are Cautiously Optimistic Ahead Of Elections In Different Countries; Optimistic Due To Expectations Of Rate Cuts; M&A And IPO Markets Are Still Below What Was Expected, That Is Not Going To Change In Q3; Private Equity Firms Will Start Selling Assets After Interest Rates Start To Fall

Wells Fargo analyst Mike Mayo maintained a Sell rating on Morgan Stanley (MS – Research Report) today and set a price target of $95.00. The company...

Morgan Stanley (MS) Gets a Sell from Wells Fargo

Buy The Dip: 10% Yields Getting Way Too Cheap

Dip Buying Opportunity: 2 Dividend Growth Stocks For Potential Long-Term Upside

In a report released today, Ken Shih from DBS maintained a Buy rating on Morgan Stanley (MS – Research Report), with a price target of $120.00. Ken...

Morgan Stanley's Growth Trajectory: A Buy Rating with Increased Target Price

Technical analysis of the stock chart for MS.

Morgan Stanley Chart Analysis

OpenAI announces new $4B credit facility with bank consortium

Morgan Stanley upgraded to Buy at HSBC on investment banking, wealth strength

In a report released today, Daniel Fannon from Jefferies maintained a Buy rating on Morgan Stanley (MS – Research Report), with a price target of $...

Comments

Morgan Stanley

空売り

Morgan Stanley (NYSE:MS) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル